(Z)-methyl 3-(2-oxopyrrolidin-1-yl-3-phenylacrylate

(Z)-methyl 3-(2-oxopyrrolidin-l-vO-3-phenylacrylate (3a )

Ή NMR (400 MHz, CDC1₃) δ 7.47-7.38 (m, 5H), 6.27 (s, 1H), 3.75 (s, 3H), 3.55 (t, J = 7.0 Hz, 2H), 2.60 (t, J = 8.0 Hz, 2H), 2.22-2.15 (m, 2H);  



¹³C NMR (100 MHz, CDC1₃) δ 175.35, 165.02, 148.23, 134.75, 130.60, 128.95, 127.06, 1 14.46, 51.59, 49.12, 31.68, 19.18;


HRMS (ESI) m/z [M+H]+: Calcd for Ci₄H,₆N0₃: 246.1 130 Found: 246.1 139.










(Z)methyl 3-(4-methoxyphenyl)-3- -oxopyrrolidin-l -yl acrylate (3 b)

Ή NMR (400 MHz, CDC1₃) δ 7.41 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 6.21 (s, 1H), 3.84 (s, 3H), 3.74 (s, 3H), 3.56 (t, J = 7.0 Hz, 2H), 2.60 (t, J = 8.0 Hz, 2H), 2.23-2.15 (m, 2H);  


^,3C NMR (100 MHz, CDC1₃) δ 175.44, 165.13, 161.68, 148.32, 128.56, 126.94, 1 14.38, 1 12.38, 55.42, 51.46, 49.26, 31.72, 19.21 ;


HRMS (ESI) m/z [M+H]+: Calcd for Ci₅H,₈N0₄: 276.1236 Found: 276.1239.







http://www.google.com/patents/WO2012173572A1?cl=en

TAKE A FREE TOUR

Cape Point. SOUTH AFRICA





















.....


DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

Join me on Facebook FACEBOOK

Join me on twitter     

Join me on google plus Googleplus

 amcrasto@gmail.com

 

///////////